Abstract: Diversity in T cell recognition of antigens is determined by diverse usage of T cell receptor (TCR) repertoire. TCR repertoire analysis provides fundamental information for understanding T cell immune responses in the pathogenesis of various diseases. In the present study, we examined the TCR repertoire in various tissues in normal BALB/c mice. The TCR α chain variable region repertoires were consistent among the spleen, lymph nodes, and the thymus. The TCR b chain variable region (TCRBV) repertoires were consistent between the spleen and lymph nodes, but different in the thymus. The TCR repertoires also differed in the lungs and the intestinal tract. The TCR repertoires were consistent between male and female mice, except for TCRBV15-1. TCR repertoire was almost similar in 3-and 7-week-old mice, except for TCRBV1-1, 8-3, and 14-1. The present findings suggest that the TCR repertoire of mice varies according to tissue type, sex and age. Additional analysis of the TCR repertoire, i.e., the effect of hydrocortisone (HC), was carried out. After the HC treatment, although the thymic T cells decreased to one-tenth, only a small fraction of CD4 + CD8 + T cells survived the treatment. Furthermore, the percentages of thymic T cells bearing TCRBV3-1, 5-1, 5-2, and 16-1 substantially decreased, but the percentage of cells bearing TCRBV12-1 did not decrease. The present findings suggest that the HC susceptibility of immature thymic T cells is different between TCR families.
Introduction
Diversity in antigen recognition is established by TCR α and b gene rearrangements through several stages of differentiation and maturation in the thymus [7, 8, 12, 18] . In addition to rearrangements of the TCR α and b genes comprising variable (V), diversity (D), and joining (J) loci, random nucleotide insertions (N regions) occur in the D-J region, leading to the formation of enormously diverse TCR repertoire [4] . After completion of TCR gene rearrangement in the cortex of the thymus, T cells migrate to the medulla. Through positive and negative selection, only clones with moderate affinities for major histocompatibility complex (MHC) molecules are selected. The selected T cells then emigrate from the thymus to the peripheral lymphatic tissues. The peripheral T cells recognize peptide fragments presented by MHC molecules via their TCRs, subsequently becoming activated, and produce various cytokines and proliferate.
T cells play important roles in recovery from infectious diseases [6, 23] as well as in the pathogenesis of allergic and autoimmune diseases [1, 17, 22, 27] . Analysis of TCR repertoires provides important information for understanding immunopathological mechanisms. As a base for TCR repertoire analyses in diseases, it is necessary to determine the TCR repertoires in the tissues of healthy individuals.
The effects of HC administration on T cells in the thymus have been described. Although HC treatment causes massive deletion of immature thymocytes, the biological significance of the effect of HC on thymocyte differentiation still remains unsolved. The HC-resistant thymocyte population, considered to be equivalent to medullary thymocytes, has similar phenotypes and functions to those of mature T cells [3, 10, 11] . On the other hand, it is known that the thymic cortex CD62 + T cell shows HC resistance [20] . Generally, the HC affects various responses in vivo such as blood pressure, glucose elevation, anti-inflammatory action, and immunosuppression. However, there is no detailed report of the TCR repertoire of the HC response in the thymus.
In the present study, we analyzed the relative expression levels of CD3, a T cell marker, and usage of TCR repertoires in various tissues in BALB/c mice. We also compared the TCR repertoires between male and female mice, and between 3-week-old (sexual immature group) and 7-week-old (sexual mature group) mice. Furthermore, we examined the TCR repertoire in BALB/c mice after HC administration, and compared the TCR repertoire of the thymus, with those of the peripheral lymphatic organ, the spleen. To analyze the TCR repertoires, we used adaptor-ligation-mediated PCR (AL-PCR) and microplate hybridization assay (MHA) methods [6, 13, 23, 28] . Generally, other previous methods of TCR analysis were using many TCRV specific probes in independent PCRs. However, precise quantification was difficult, because amplification efficiencies differ among individual primers. The AL-PCR ligates universal primer to the variable region 5' end of the TCR gene and is able to amplify all TCR genes in one PCR. Moreover, the MHA has V/C values which have coherent strict color development intensities for all TCR genes determined by the ratio of the hybridization intensity of each TCR variable region-specific probe to that of the corresponding TCR constant region-specific probe. The analysis of the relative abundances of the TCRs are related to the MHA, the mRNA of the TCR gene, and the FACS analysis using monoclonal antibodies for each TCR [28] . Therefore, TCR repertoire analysis using the AL-PCR and MHA methods enables us to amplify and measure all the variable regions of the rearranged TCR genes without any artificial skewing.
Materials and Methods

Animals
Specific pathogen free (SPF) BALB/cAnCrj (H-2 d ) mice were purchased from Charles River Japan Inc. (Tokyo, Japan 
Real-time PCR
The CD3 mRNA expression levels in the total RNA samples were examined by real-time PCR using a LightCycler apparatus (Roche Diagnostics, Basel, Switzerland). Total RNA (500 ng) was converted to cDNAs using a PrimeScript™ RT Reagent Kit (Takara Bio, Otsu, Japan) according to the manufacturer's instructions. PCR amplification was performed using SYBR ® Premix Taq™ (Takara Bio) for SYBR ® Green I. A primer pair specific for CD3 (forward primer: CACTCTGGGCT-TGCTGATGG; reverse primer: TCATAGTCTGGGT-TGGGAACAGG) was purchased from Takara Bio. Briefly, the PCR amplification was carried out in a 20-µl final volume containing 2 µl of DNA template, 0.4 µl of 10 µM solutions of the CD3 forward and reverse primers, 10 µl of SYBR ® Premix Taq™ and H 2 O up to 20 µl.
After an initial denaturation step at 95°C for 10 s, 50 cycles of 95°C for 5 s and 60°C for 30 s were performed, with measurement of the fluorescence at the end of each cycle. Immediately after the amplification, a melting curve analysis was performed from 65°C to 95°C at a linear temperature transition rate of 0.1°C/s with continuous recording of fluorescence. The absolute copy numbers of unknown samples were calculated by comparing the threshold cycles with the corresponding standard curve. A reference cDNA was used in every assay to correct experimental variations among assays. The cDNA levels among samples were normalized by the expression level of the internal control gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [25] . Quantification was based on the relative ratio between each unknown sample and the reference sample. To include all measurement mRNAs, the reference sample was mixed with total RNA of various organs and tissues.
AL-PCR
To analyze the TCR repertoires, samples were amplified by AL-PCR as previously described [13, 28] . Briefly, freshly isolated RNA (1 µg) was converted to doublestranded cDNAs using SuperScript™ II RNase H -Reverse
Transcriptase (Invitrogen, California, USA) according to the manufacturer's instructions, except that a specific primer (BSL-18E) was used. P10EA/P20EA adaptors were ligated to the 5' ends of the cDNAs and the adaptorligated cDNAs were cut with SphI. First and second PCR amplifications were performed with TCR α chain constant region (TCRAC)-specific or TCR b chain constant region (TCRBC)-specific primers and P20EA. A third PCR amplification was performed using both P20EA and 5'-biotinylated TCRAC-or TCRBC-specific primers for biotinylation of PCR products. All PCR amplifications were performed in triplicate.
MHAs
The TCR α chain variable region (TCRAV) and TCR b chain variable region (TCRBV) repertoires were analyzed by MHAs [13, 14, 28] . Briefly, 10 pmol of aminomodified oligonucleotides specific for TCRAV and TCRBV segments were immobilized in carboxylatemodified 96-well microplates (C type; Sumitomo Bakelite, Tokyo, Japan) with water-soluble carbodiimide. The probes used in the present study were described previously [28] . The names of the TCR families and probes were designed in order of the genomic TCR gene name, except for the pseudogene. Prehybridization and hybridization were performed in GM Church (GMC) buffer (pH 7.0) comprising 0.5 M Na 2 HPO 4 , 1 mM EDTA, 7% SDS and 1% BSA at 47°C. Denatured 5'-biotinylated PCR products (40 µl) were mixed with an equivalent volume of 0.4 N NaOH/10 mM EDTA, and added to 4 ml of GMC buffer. An aliquot (100 µl) of the hybridization solution was placed in each well of the microplate containing immobilized oligonucleotide probes specific for the V segment. After hybridization, the wells were washed six times with washing buffer (2 × SSC, 0.1% SDS) at room temperature. For stringent washing, the plate was incubated at 37°C for 10 min. After three washes, 200 µl of TB-TBS buffer (pH 7.4) comprising 10 mM Tris-HCl, 0.5 M NaCl, 0.5% Tween 20, and 0.5% blocking reagent (Roche Diagnostics, Mannheim, Germany) was added to block non-specific binding. Next, 100 µl of alkaline phosphatase-conjugated streptavidin (R&D Systems, Minnesota, USA) diluted 1:5000 in TB-TBS was added, and the plate was incubated at 37°C for 30 min. After six washes in T-TBS (10 mM Tris-HCl pH7.4, 0.5 M NaCl, 0.5% Tween 20), color development was initiated by adding 100 µl of substrate solution, 4 mg/ml p-nitrophenylphosphate (Nacalai Tesque, Kyoto, Japan), to 10% diethanolamine (pH 9.8). After 1 h, the absorbance was determined at 405 nm. Data were analyzed using the Ascent software package (Thermo Fisher Scientific, Massachusetts, USA). The V/C value was determined using TCR cDNA-concentrated samples containing the appropriate V segment and the universal C segment, respectively [28] . The absorbance obtained for each TCRV-specific probe was divided by the corresponding V/C value. The relative frequencies were calculated based on the corrected absorbance using the following formula: relative frequency (%) = [(corrected absorbance of TCRV-specific probe) / (sum of corrected absorbance of TCRV-specific probes)] × 100.
Study 2: Analysis of TCR repertoire in HC treated mice
The HC treatment of mice was performed by a modified Reichert et al. method [20] . In brief, a group of five 3-week-old male mice were administered i.p. with 5.0 mg of HC acetate (Wako, Osaka, Japan) dissolved in 200 µl of saline. A separate group of five mice were administered i.p. with 200 µl of saline and served as controls. At 48 h after the administration, all mice were sacrificed by exsanguination under isoflurane anesthesia, and their thymuses and spleens were collected. In these samples, flow cytometry analysis and TCR repertoire analysis (according to the method of total RNA isolation, AL-PCR and MHAs) were carried out.
Flow cytometry analysis
Cell suspensions were prepared in PBS containing 5% BSA (BSA-PBS). Thymus and spleen cells were stained with the following monoclonal antibodies: CyChromeconjugated American Hamster anti-CD3e (145-2C11; BD PharMingen, New Jersey, USA); fluorescein isothiocyanate (FITC)-conjugated rat anti-CD4 (H129.19; BD PharMingen); and phycoerythrin (PE)-conjugated rat anti-CD8a (53-6.7; BD PharMingen). After staining, cells were washed with BSA-PBS and analyzed on a FACSCalibur flow cytometer (Becton Dickinson, California, USA) using the CellQuest software. Cells were gated on forward scatter/ side scatter plots and then on CD3.
Statistical analysis
Differences between groups were analyzed by Student's paired t-test using StatView 5.0 for Windows (SAS Institute, North Carolina, USA). P values of <0.05 were accepted as statistically significant.
Results
Comparison of CD3 expression in various organs
The CD3 mRNA expression levels were analyzed in the spleen, lymph nodes, the thymus, the lung, the intestinal tract, the liver, the genital organs (uterus and seminal vesicles), the bone marrow, and the brain of normal 3-week-old male BALB/c mice ( Table 1 ). The expression levels of CD3 in the spleen, lymph nodes and the thymus were notably greater than those in the lung and the intestinal tract. Whereas the liver, genital organs (the uterus and the seminal vesicle), the bone marrow, and the brain expressed extremely low levels of CD3 compared to the lung and the intestinal tract. Similar CD3 expression patterns were found in female mice (data not shown). 
Determination of TCRAV and TCRBV repertoires in tissues
The TCR repertoires of 3-week-old male BALB/c mice were analyzed in various organs and representative TCR repertoires are shown in Fig. 1 . The TCRAV repertoires were consistent among the spleen, lymph nodes, and thymus, while the TCRBV repertoires were consistent between the spleen and lymph nodes. The TCRBV TCR are shown for the spleen, lymph nodes, the thymus, the lung, and the intestinal tract. Vertical error bars indicate the standard deviation of five independent experiments. In the thymus, the percentages of cells bearing TCRBV3-1, 5-1, 5-2, 12-1, and 16-1 were significantly increased (P<0.05; black arrows and bars) and the percentages of cells bearing TCRBV1-1 and 15-1 were significantly decreased (P<0.05; white arrows and bars) compared with the corresponding levels in the spleen. In the lungs and the intestinal tract, percentages of cells bearing TCRBV19-1 and 20-1 were significantly increased (P<0.05; black arrows and bars) and the percentages of cells bearing TCRBV8-2 and 14-1 were significantly decreased (P<0.05; white arrows and bars) compared with the corresponding levels in the spleen.
repertoires in the thymus differed from those in the spleen and lymph nodes. In the thymus, the percentages of cells bearing TCRBV3-1, 5-1, 5-2, 12-1, and 16-1 were significantly increased and those of cells bearing TCRBV1-1 and 15-1 were significantly decreased in comparison with the spleen and lymph nodes. The TCRAV and TCRBV repertoires in the lung and intestinal tract differed from those in the spleen, lymph nodes, and the thymus. Smaller numbers of TCRBV8-2-and TCRBV14-1-bearing cells were detected in the lung and the intestinal tract compared to the lymphatic organs. On the other hand, though virtually no TCRBV19-1-and TCRBV20-1-bearing cells were detected in the spleen, lymph nodes, and the thymus, they were apparently present in the intestinal tract and, to a lesser extent, in the lung.
Smaller numbers of subfamilies were detected with weak signals in the liver, seminal vesicles, uterus, bone marrow, and brain and their repertoires differed from those in the spleen, lymph nodes, and the thymus (data not shown).
Comparison of TCR repertoires in mice of different sexes and ages
The TCRBV repertoires were analyzed in the spleen, lymph nodes, and the thymus from 3-and 7-week-old male and female mice (12 groups). The TCRBV repertoires in mice of each sex and age are shown in Fig. 2 . The percentages of TCRBV15-1-bearing cells were significantly higher in males than in females in both age groups, but there were no apparent differences in any of the other TCR repertoires. On the other hand, the percentage of TCRBV1-1-bearing cells was significantly decreased in the spleen, lymph nodes, and the thymus in 7-week-old mice compared with 3-week-old mice, whereas the percentages of TCRBV8-3-and 14-1-bearing cells were significantly increased in lymphatic organs of older mice.
Alterations in T cell populations in the thymus and spleen induced by HC administration (Table 2)
The number of thymic T cells decreased from 32.5 × 10 7 to 2.9 × 10 7 after HC administration, indicating the dose adopted in this study was effective. In control mice, approximately 80% of the thymic lymphocytes were 
Alterations in TCR repertoire in the thymus and spleen induced by HC
The alterations observed in the TCR repertoire are shown in Fig. 3 . The percentages of cells bearing TCR-BV3-1, 5-1, 5-2, and 16-1 in the thymus significantly decreased in HC-treated mice compared with control mice. On the contrary, the percentage of cells bearing TCRBV1-1 in the thymus significantly increased in HCtreated mice. Cells bearing TCRBV15-1 and 16-1 in the spleen significantly decreased in HC-treated mice. The VB1-1 spleen T cells increased in number though not significantly.
Discussion
The thymus showed an unique TCRBV expression pattern among the organs examined in this study. Endogenous superantigens (SAGs) derived from mouse mammary tumor virus (MMTV) affect TCR repertoire by deleting T cells bearing particular VB chains either partially or completely in the thymus and peripheral lymphatic organs [2, 5, 21, 26] . BALB/c (H-2 d ) mice express the Mtv-6, -8, and -9 genes from MMTV. The Mtv-6 SAG deletes TCRBV3 + cells, while the Mtv-8 SAG deletes both TCRBV11 + and 12 + T cells [2, 21] .
The Mtv-9 SAG induces clonal deletion of T cells bearing TCRBV5-1, 5-2, 11, and 12 [2, 21] . The expression patterns shown in the present study revealed that the percentages of virtually all these TCRBV subfamilies were low in peripheral lymphatic tissues, consistent with 49.5 ± 9. the previous reports. TCRBV11 + T cells, supposed to be deleted in BALB/c mice, however, were not deleted in the peripheral lymphatic tissues. We cannot think of an appropriate reason for this discrepancy. In addition, TCRBV16 + T cells were incompletely deleted in the periphery, implying an alternative mechanism for the deletion of particular T cell clones other than SAGs. The higher frequency of TCRBV15 + T cells in lymph nodes and the spleen compared to the thymus suggest that another unknown peripheral positive selection or expansion mechanism is at work in the peripheral lymphatic organs. Weak but detectable TCR signals were seen in the lung and intestinal tract. The lung, exposed to airborne foreign antigens through ventilation, possesses bronchusassociated lymphoid tissues (BALTs) [15] . Similarly, the intestinal tract, constantly exposed to food antigens and bacterial flora, has gut-associated lymphoid tissues (GALTs) [24] . Interestingly, in both the lung and the intestinal tract, although a TCR repertoire was observed that was generally consistent with that of the spleen and lymph nodes, TCRBV8-2 + and 14 + T cell numbers were decreased, whereas those of TCRBV19-1 + and 20-1 + T cells were increased. Since these organs have external milieu within and are exposed to external antigens, this condition might cause unique TCR repertoire changes (decrease of TCRBV8-2 + and 14 + T cells, and increase of TCRBV19-1 + and 20-1 + T cells). Unknown selection mechanisms may be functioning in the lung and in the intestinal tract. It was reported recently that an intestinal indigenous microbiota affect gene expression and cell activity of T cell, in a comparative study of SPF and germ free mice [9, 16] . The fact that the extent of expression of TCRBV19-1 and 20-1 in lymphocytes from the intestinal tract was greater than that from the lung may be due to the exposure to indigenous microbiota and/or food antigens. To address this issue, analyses with germ free animals would be gently helpful. Sufficiently high signals for TCR analysis were not obtained for the liver, genital organs, the bone marrow and the brain. The relative CD3 mRNA expression levels were also low in these organs, suggesting that they contained only small T cell populations.
We further investigated whether the TCR repertoire would vary in normal mice according to sex and age.
The frequency of TCRBV15-1-bearing cells was found to be higher in male than in female mice, irrespective of the age of the lymphatic tissues examined. The frequencies of TCRBV1-1-, 8-3-, and 14-1-bearing cells differed with age, with TCRBV8-3 and 14-1 higher showing in older mice.
The precise mechanisms behind these differences remain unknown. Various T cell selection systems, positive and/or negative, might be in operation systematically and/or locally, responding to genetic (sex) and/or environmental (tissue types and age) changes, leading to the alteration of the T cell repertoire. It is interesting, though, that indistinguishable age-dependent changes in the frequencies of TCRBV1-1-, 8-3-, and 14-1-bearing cells were found irrespective of the type of lymphatic tissue. In age-dependent changes, either an identical selection mechanism would operate in different lymphatic tissues including the thymus and lymph nodes, or similar genetic alterations would occur. Further extensive investigations of this are necessary.
HC-administered mice were found to have decreased numbers of CD4 + CD8 + T cells in the thymus, suggesting that CD4 + CD8 + T cells are HC-sensitive as previously reported [20] . The TCR repertoire in the thymus was also altered by HC treatment, as indicated by the decreased numbers of cells bearing TCRBV3-1, 5-1, 5-2, and 16-1. In peripheral T cells, MMTV sensitization causes clonal deletion of a proportion of the TCR families, including cells bearing TCRBV3-1, 5-1, 5-2, and 12-1 [2, 5, 21, 26] . In the present study, cells bearing TCRBV3-1, 5-1, and 5-2 in the thymus were found to be HC-sensitive. The numbers of these cells were greatly decreased, but they were not completely eliminated.
In the spleen, however, these cell subsets were not significantly decreased by HC treatment. The reason for the increase in cells bearing TCRBV1-1 remains unknown, but a relative increase might have occurred due to a reduction in number of other TCRBV cells. On the other hand, one population, TCRBV12-1, partially deleted in the periphery after MMTV sensitization [2, 21] , was found to be HC-resistant in this study. Cells bearing TCRBV16-1, which are unaffected by MMTV-sensitization, decreased in both the spleen and the thymus after HC administration. Therefore, TCRBV3-1, 5-1, and 5-2 are sensitive to both MMTV and HC, while TCRBV12-1 is sensitive only to MMTV and TCRBV16-1 is sensitive only to HC. We think that the sensitivity of TCR cells against MMTV or HC are totally disparate. Thus, HC, a potent endogenous stimulus, might create an entirely different environment within, leading to an alternative immune status of downregulating or overreacting to various antigens. In the spleen, HC administration was found to decrease the number of T cells only slightly. Cells bearing TCRBV15-1 in the spleen, however, decreased significantly after HC administration. The counterpart subset in the thymus was not decreased by HC, suggesting TCRBV15-1 thymocytes are not identical to those in the spleen. The extent of deletion of some TCRBV families may be due to MMTV and/or other endogenous stimuli, like steroid hormones. In fact, completely deleted families were TCRBV3-1, 5-1, and 5-2, and partially deleted families were TCRBV12-1 and TCRBV16-1. It is possible that the difference of HC and/or MMTV sensibility in thymocytes influences the deletion level of peripheral T cells to suggesting the HC-resistant thymic lymphocyte is not equivalent to the medullary thymocyte, and that the HC-sensitive immature thymic lymphocyte is different among TCRBV families.
